Matthew G Hanna, MD, FCAP, Artificial Intelligence (AI) Committee Chair, discusses digital pathology software. Hanna said that some healthcare providers in the US have validated those RUO products for clinical use as laboratory-developed tests.
For the full article click here: Aiosyn Growing Team, Ramping up Sales of Breast Cancer Mitosis Detection Tool